Benzinga Weekly Preview: U.S. Data In Focus

With Independence Day shutting US markets down for a long weekend, next week will be a slow week for earnings reports.

However, an influx of economic data will more than make up for it and give investors plenty to consider. US data is expected to show that the nation’s recovery is back on track with both jobs data and PMI data forecast to impress.

Fed Chair Janet Yellen is set to speak at the International Monetary Fund on Wednesday, a talk that will be closely watched as investors look for clues about the bank’s policy tightening timeline.

Key Earnings Reports

Next week, investors will be waiting for several key earnings reports including Paychex (NASDAQ: PAYX), Constellation Brands (NYSE: STZ) and Unifirst (NYSE: UNF)

Paychex Inc

Paychex is expected to report fourth quarter EPS of $0.40 on revenue of $617.35 million, compared to last year’s EPS of $0.38 on revenue of $585.30 million.

On March 28, Merrill Lynch maintained Paychex at a Neutral rating with a $47.00 price objective, noting that competition among payroll providers was high and may have an impact on the company’s growth.

“PAYX continues to face increased competition from SaaS-based payroll providers & Intuit, among others. Management noted that both its SurePayroll (SaaS offering) and full-service offerings with added online features are growing well. We expect Paychex will compete effectively but have concerns that growth in SaaS-based payroll offerings may limit pricing power for the full-service offering over time. Paychex should benefit from an improving cyclical market and greater reliance on payroll data due to healthcare reform. However, questions remain around the competitive environment. Valuation incorporates much of the improving cycle, with PAYX trading at 22x CY15E EPS, in line with its 22x 10 year median forward P/E. We maintain our $47 price objective, based on 24.5x CY15E EPS of $1.92.”

A day earlier, on March 27, Credit Suisse had a similar opinion on Paychex with a Neutral rating and a $41.00 price target. The analysts at Credit Suisse said the company’s shares are already fully valued and that there was little upside to be seen in the near future.

“Despite investments in the business via M&A, JVs, and revamping its omnichannel user experience, PAYX's profitability continues to increase. While operating margin (ex-float) guidance suggests a sequential and y-o-y contraction we view this as conservative given the ~130 bps of expansion through the first nine months. PAYX currently trades at ~24x our CY14 EPS, a considerable premium to the peer group average of 17x). With PAYX's relatively anemic growth prospects (high-single-digit EPS growth) we do not see any significant upside to the current share price.”